Please sign in to follow a disease.

Follicular grade 3 lymphoma

Clinical trials for Follicular grade 3 lymphoma explained in plain language.

Never miss a new study

Get alerted when new Follicular grade 3 lymphoma trials appear

Sign up with your email to follow new studies for Follicular grade 3 lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Can a Macrophage-Targeting drug supercharge CAR-T therapy?

Disease control Not yet recruiting

This trial tests whether adding a drug called axatilimab to standard CAR-T cell therapy can improve outcomes for people with high-risk large B-cell lymphomas. Axatilimab works by conditioning macrophages, a type of immune cell, to potentially help the CAR-T cells fight cancer mor…

Matched conditions: FOLLICULAR GRADE 3 LYMPHOMA

Phase 1 • Sponsor: Northside Hospital, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

Follicular grade 3 lymphoma

Get alerted when new Follicular grade 3 lymphoma trials appear

Can a Macrophage-Targeting drug supercharge CAR-T therapy?